Immix Biopharma (IMMX) Prepaid Assets (2020 - 2026)

Immix Biopharma has disclosed Prepaid Assets across 7 years of filings, most recently posting $335739.0 for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $335739.0, up 98.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $335739.0 (up 98.56% YoY), and the FY2025 annual result was $828329.0, up 52.97% from the prior year.
• Prepaid Assets came in at $335739.0 for Q1 2026 at Immix Biopharma, down from $828329.0 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q2 2023 to a low of $36521.0 in Q3 2024.
• The 5-year median for Prepaid Assets is $292047.0 (2022), against an average of $546886.5.
• Across the five-year window, Prepaid Assets sank 96.3% in 2023 and surged 1114.64% in 2024, its largest moves.
• Immix Biopharma's Prepaid Assets stood at $1.2 million in 2022, then tumbled by 96.3% to $44582.0 in 2023, then soared by 1114.64% to $541510.0 in 2024, then soared by 52.97% to $828329.0 in 2025, then plunged by 59.47% to $335739.0 in 2026.
• The last three Prepaid Assets figures came in at $335739.0 (Q1 2026), $828329.0 (Q4 2025), and $49647.0 (Q3 2025), per Business Quant data.